image
Real Estate - REIT - Retail - NYSE - US
$ 75.97
0.503 %
$ 7.86 B
Market Cap
41.97
P/E
1. INTRINSIC VALUE

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol "ADC".[ Read More ]

The intrinsic value of one ADC stock under the base case scenario is HIDDEN Compared to the current market price of 76 USD, Agree Realty Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ADC

image
FINANCIALS
537 M REVENUE
16.05%
254 M OPERATING INCOME
16.65%
171 M NET INCOME
11.44%
392 M OPERATING CASH FLOW
8.14%
-1.27 B INVESTING CASH FLOW
21.10%
869 M FINANCING CASH FLOW
-29.78%
154 M REVENUE
1.15%
74.4 M OPERATING INCOME
-0.47%
44.5 M NET INCOME
-18.63%
140 M OPERATING CASH FLOW
51.18%
-247 M INVESTING CASH FLOW
-50.25%
95.4 M FINANCING CASH FLOW
18.91%
Balance Sheet Decomposition Agree Realty Corporation
image
Current Assets 101 M
Cash & Short-Term Investments 10.9 M
Receivables 83 M
Other Current Assets 7.26 M
Non-Current Assets 7.67 B
Long-Term Investments 0
PP&E 6.8 B
Other Non-Current Assets 870 M
Current Liabilities 1.84 B
Accounts Payable 26.5 M
Short-Term Debt 6.55 M
Other Current Liabilities 1.8 B
Non-Current Liabilities 2.49 B
Long-Term Debt 65.9 M
Other Non-Current Liabilities 2.42 B
EFFICIENCY
Earnings Waterfall Agree Realty Corporation
image
Revenue 537 M
Cost Of Revenue 240 M
Gross Profit 298 M
Operating Expenses 216 M
Operating Income 254 M
Other Expenses 83.8 M
Net Income 171 M
RATIOS
55.41% GROSS MARGIN
55.41%
47.33% OPERATING MARGIN
47.33%
31.62% NET MARGIN
31.62%
3.27% ROE
3.27%
2.19% ROA
2.19%
4.81% ROIC
4.81%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Agree Realty Corporation
image
Net Income 171 M
Depreciation & Amortization 175 M
Capital Expenditures 0
Stock-Based Compensation 8.34 M
Change in Working Capital 5.42 M
Others 32.8 M
Free Cash Flow 392 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Agree Realty Corporation
image
Wall Street analysts predict an average 1-year price target for ADC of $66.1 , with forecasts ranging from a low of $48 to a high of $80 .
ADC Lowest Price Target Wall Street Target
48 USD -36.82%
ADC Average Price Target Wall Street Target
66.1 USD -12.94%
ADC Highest Price Target Wall Street Target
80 USD 5.30%
4. DIVIDEND ANALYSIS
1.02% DIVIDEND YIELD
0.253 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Agree Realty Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
1.25 M USD 2
3-6 MONTHS
3.53 M USD 4
6-9 MONTHS
1.75 M USD 4
9-12 MONTHS
Date Value Insider Amount Avg Price
5 months ago
May 23, 2024
Bought 594 K USD
RAKOLTA JOHN JR
Director
+ 10000
59.4 USD
5 months ago
May 23, 2024
Bought 592 K USD
RAKOLTA JOHN JR
Director
+ 10000
59.24 USD
5 months ago
May 23, 2024
Bought 59 K USD
Lehmkuhl Greg
Director
+ 1000
58.99 USD
8 months ago
Mar 14, 2024
Bought 24.9 K USD
Breslin Stephen
CHIEF ACCOUNTING OFFICER
+ 450
55.33 USD
8 months ago
Feb 29, 2024
Bought 888 K USD
AGREE RICHARD
EXECUTIVE CHAIRMAN OF BOARD
+ 16000
55.5 USD
8 months ago
Feb 21, 2024
Bought 199 K USD
Agree Joey
PRESIDENT & CEO
+ 3500
56.92 USD
8 months ago
Feb 21, 2024
Bought 1.14 M USD
RAKOLTA JOHN JR
Director
+ 20000
56.75 USD
8 months ago
Feb 20, 2024
Bought 5.82 K USD
RAKOLTA JOHN JR
Director
+ 102
57.09 USD
9 months ago
Feb 16, 2024
Bought 1.16 M USD
RAKOLTA JOHN JR
Director
+ 20430
57 USD
9 months ago
Feb 15, 2024
Bought 115 K USD
Agree Joey
PRESIDENT & CEO
+ 2000
57.56 USD
10 months ago
Jan 10, 2024
Bought 657 K USD
AGREE RICHARD
EXECUTIVE CHAIRMAN OF BOARD
+ 10500
62.57 USD
10 months ago
Dec 21, 2023
Bought 20.9 K USD
RAKOLTA JOHN JR
Director
+ 335
62.41 USD
10 months ago
Dec 20, 2023
Bought 812 K USD
RAKOLTA JOHN JR
Director
+ 13000
62.44 USD
11 months ago
Dec 15, 2023
Bought 104 K USD
Lehmkuhl Greg
Director
+ 1700
61.17 USD
11 months ago
Dec 11, 2023
Bought 76 K USD
Agree Joey
PRESIDENT & CEO
+ 1300
58.49 USD
11 months ago
Dec 11, 2023
Bought 78.9 K USD
Agree Joey
PRESIDENT & CEO
+ 1350
58.47 USD
1 year ago
Oct 02, 2023
Bought 215 K USD
Agree Joey
PRESIDENT & CEO
+ 4000
53.84 USD
1 year ago
Sep 28, 2023
Bought 99.4 K USD
Erlich Craig
CHIEF GROWTH OFFICER
+ 1800
55.2481 USD
1 year ago
Sep 26, 2023
Bought 1.11 M USD
RAKOLTA JOHN JR
Director
+ 20000
55.73 USD
1 year ago
Sep 26, 2023
Bought 561 K USD
Agree Joey
PRESIDENT & CEO
+ 10000
56.1 USD
1 year ago
Sep 21, 2023
Bought 1.72 M USD
RAKOLTA JOHN JR
Director
+ 30000
57.48 USD
1 year ago
Aug 15, 2023
Bought 30.9 K USD
Coughenour Peter
CHIEF FINANCIAL OFFICER
+ 500
61.79 USD
1 year ago
Aug 14, 2023
Bought 93.5 K USD
Erlich Craig
CHIEF OPERATING OFFICER
+ 1500
62.36 USD
1 year ago
Aug 14, 2023
Bought 9.66 K USD
Erlich Craig
CHIEF OPERATING OFFICER
+ 155
62.33 USD
1 year ago
Aug 14, 2023
Bought 6.24 K USD
Erlich Craig
CHIEF OPERATING OFFICER
+ 100
62.39 USD
1 year ago
Aug 03, 2023
Bought 581 K USD
AGREE RICHARD
EXECUTIVE CHAIRMAN OF BOARD
+ 9125
63.7 USD
1 year ago
Aug 03, 2023
Bought 581 K USD
AGREE RICHARD
EXECUTIVE CHAIRMAN OF BOARD
+ 9124
63.7 USD
1 year ago
Aug 02, 2023
Bought 370 K USD
AGREE RICHARD
EXECUTIVE CHAIRMAN OF BOARD
+ 5875
62.95 USD
1 year ago
Aug 02, 2023
Bought 370 K USD
AGREE RICHARD
EXECUTIVE CHAIRMAN OF BOARD
+ 5876
62.95 USD
1 year ago
Aug 02, 2023
Bought 628 K USD
Agree Joey
PRESIDENT & CEO
+ 10000
62.79 USD
1 year ago
Aug 02, 2023
Bought 1.89 M USD
RAKOLTA JOHN JR
Director
+ 30000
63.02 USD
1 year ago
May 26, 2023
Bought 32.1 K USD
Coughenour Peter
CHIEF FINANCIAL OFFICER
+ 500
64.25 USD
1 year ago
May 26, 2023
Bought 192 K USD
Erlich Craig
CHIEF OPERATING OFFICER
+ 3000
64.09 USD
1 year ago
May 25, 2023
Bought 24.1 K USD
Breslin Stephen
CHIEF ACCOUNTING OFFICER
+ 375
64.32 USD
1 year ago
May 24, 2023
Bought 325 K USD
Agree Joey
PRESIDENT & CEO
+ 5000
64.91 USD
1 year ago
May 17, 2023
Bought 98.2 K USD
Erlich Craig
CHIEF OPERATING OFFICER
+ 1500
65.5 USD
1 year ago
May 17, 2023
Bought 327 K USD
Agree Joey
PRESIDENT & CEO
+ 5000
65.35 USD
1 year ago
May 12, 2023
Bought 332 K USD
Agree Joey
PRESIDENT & CEO
+ 5000
66.36 USD
1 year ago
May 11, 2023
Bought 498 K USD
RAKOLTA JOHN JR
Director
+ 7500
66.45 USD
1 year ago
May 08, 2023
Bought 712 K USD
RAKOLTA JOHN JR
Director
+ 10495
67.85 USD
1 year ago
Dec 29, 2022
Bought 79.6 K USD
Erlich Craig
director: CHIEF OPERATING OFFICER
+ 4898
16.25 USD
1 year ago
Dec 21, 2022
Bought 785 K USD
RAKOLTA JOHN JR
Director
+ 11000
71.38 USD
2 years ago
Apr 08, 2022
Bought 14.5 K USD
RAKOLTA JOHN JR
director:
+ 213
68.09 USD
2 years ago
Mar 23, 2022
Bought 100 K USD
Agree Joey
director: PRESIDENT & CEO
+ 1560
64.23 USD
2 years ago
Mar 22, 2022
Bought 112 K USD
Agree Joey
director: PRESIDENT & CEO
+ 1749
64.03 USD
2 years ago
Dec 02, 2021
Bought 16.7 K USD
Lehmkuhl Greg
Director
+ 250
66.91 USD
3 years ago
Nov 17, 2021
Bought 34.2 K USD
Lehmkuhl Greg
Director
+ 500
68.35 USD
3 years ago
Oct 08, 2021
Bought 6.83 K USD
Frankel Merrie S.
Director
+ 100
68.2822 USD
3 years ago
Oct 05, 2021
Bought 13.3 K USD
Frankel Merrie S.
Director
+ 200
66.465 USD
3 years ago
Oct 05, 2021
Bought 6.65 K USD
Frankel Merrie S.
Director
+ 100
66.49 USD
3 years ago
Oct 05, 2021
Bought 13.3 K USD
Erlich Craig
Chief Operating Officer
+ 200
66.628 USD
3 years ago
Sep 28, 2021
Bought 402 K USD
AGREE RICHARD
Executive Chairman of Board
+ 6000
67.06 USD
3 years ago
Sep 27, 2021
Bought 18.5 K USD
RAKOLTA JOHN JR
Director
+ 273
67.8183 USD
3 years ago
Sep 27, 2021
Bought 948 K USD
RAKOLTA JOHN JR
Director
+ 14000
67.7 USD
3 years ago
Sep 27, 2021
Bought 407 K USD
RAKOLTA JOHN JR
Director
+ 6000
67.8 USD
3 years ago
Sep 24, 2021
Bought 248 K USD
Agree Joey
President & CEO
+ 3670
67.56 USD
3 years ago
Sep 17, 2021
Bought 10.1 K USD
Frankel Merrie S.
Director
+ 400
25.15 USD
3 years ago
Sep 14, 2021
Bought 7.16 K USD
Judlowe Michael
Director
+ 100
71.6 USD
3 years ago
Sep 13, 2021
Bought 33.9 K USD
Judlowe Michael
Director
+ 475
71.45 USD
3 years ago
Mar 03, 2021
Bought 627 K USD
RAKOLTA JOHN JR
Director
+ 10000
62.73 USD
3 years ago
Mar 03, 2021
Bought 127 K USD
Erlich Craig
Chief Operating Officer
+ 2000
63.74 USD
3 years ago
Mar 02, 2021
Bought 638 K USD
AGREE RICHARD
Executive Chairman of Board
+ 10000
63.77 USD
3 years ago
Mar 02, 2021
Bought 635 K USD
RAKOLTA JOHN JR
Director
+ 10000
63.5 USD
3 years ago
Mar 02, 2021
Bought 128 K USD
Leopold Simon
CFO, EVP & Secretary
+ 2000
63.75 USD
3 years ago
Mar 02, 2021
Bought 501 K USD
Agree Joey
President & CEO
+ 7870
63.61 USD
3 years ago
Feb 23, 2021
Bought 38.6 K USD
RAKOLTA JOHN JR
Director
+ 602
64.08 USD
3 years ago
Feb 23, 2021
Bought 573 K USD
RAKOLTA JOHN JR
Director
+ 8923
64.22 USD
3 years ago
Feb 22, 2021
Bought 631 K USD
RAKOLTA JOHN JR
Director
+ 10000
63.08 USD
3 years ago
Feb 22, 2021
Bought 18.9 K USD
Lehmkuhl Greg
Director
+ 300
62.93 USD
4 years ago
Nov 06, 2020
Bought 94.5 K USD
Rubenfaer William S.
Director
+ 1500
62.99 USD
4 years ago
Oct 23, 2020
Bought 530 K USD
Agree Joey
President & CEO
+ 8058
65.79 USD
4 years ago
Oct 22, 2020
Bought 474 K USD
Agree Joey
President & CEO
+ 7235
65.58 USD
4 years ago
Jun 03, 2020
Sell 135 K USD
Rossi Jerome R
Director
- 2000
67.485 USD
4 years ago
May 14, 2020
Bought 82.9 K USD
Leopold Simon
Director
+ 1500
55.25 USD
4 years ago
May 13, 2020
Bought 23.6 K USD
Lehmkuhl Greg
Director
+ 400
58.92 USD
4 years ago
Apr 03, 2020
Bought 5.69 K USD
Frankel Merrie S.
Director
+ 100
56.92 USD
4 years ago
Apr 03, 2020
Bought 28.2 K USD
Frankel Merrie S.
Director
+ 500
56.48 USD
4 years ago
Apr 03, 2020
Bought 20.2 K USD
Lehmkuhl Greg
Director
+ 350
57.74 USD
4 years ago
Mar 24, 2020
Bought 112 K USD
Rossi Jerome R
Director
+ 2000
56.12 USD
4 years ago
Mar 18, 2020
Bought 7.48 K USD
Erlich Craig
Director
+ 150
49.9 USD
4 years ago
Mar 18, 2020
Bought 7.34 K USD
Erlich Craig
Director
+ 150
48.96 USD
4 years ago
Mar 17, 2020
Bought 17.2 K USD
Frankel Merrie S.
Director
+ 300
57.33 USD
4 years ago
Mar 16, 2020
Bought 12.4 K USD
Lehmkuhl Greg
Director
+ 200
61.95 USD
4 years ago
Mar 16, 2020
Bought 12.1 K USD
Lehmkuhl Greg
Director
+ 200
60.5 USD
5 years ago
Jun 05, 2019
Bought 32.8 K USD
Lehmkuhl Greg
Director
+ 500
65.6 USD
4 years ago
Mar 09, 2020
Bought 72.6 K USD
Leopold Simon
Director
+ 1000
72.6 USD
4 years ago
Dec 17, 2019
Bought 136 K USD
Rubenfaer William S.
Director
+ 2000
67.92 USD
4 years ago
Dec 16, 2019
Bought 6.83 K USD
Erlich Craig
Director
+ 100
68.34 USD
4 years ago
Dec 16, 2019
Bought 6.84 K USD
Erlich Craig
Director
+ 100
68.36 USD
4 years ago
Dec 16, 2019
Bought 4.99 K USD
Erlich Craig
Director
+ 73
68.39 USD
4 years ago
Dec 16, 2019
Bought 821 K USD
AGREE RICHARD
Executive Chairman of Board
+ 12000
68.44 USD
4 years ago
Dec 13, 2019
Bought 682 K USD
AGREE RICHARD
Executive Chairman of Board
+ 10000
68.19 USD
4 years ago
Dec 12, 2019
Bought 34.8 K USD
Lehmkuhl Greg
Director
+ 500
69.55 USD
4 years ago
Dec 09, 2019
Bought 36.3 K USD
Lehmkuhl Greg
Director
+ 500
72.69 USD
5 years ago
Jul 01, 2019
Bought 3.17 K USD
Agree Joey
President & CEO
+ 50
63.48 USD
5 years ago
Jul 01, 2019
Sell 65.9 K USD
KALIL FARRIS G.
Director
- 1034
63.7 USD
5 years ago
Jun 26, 2019
Bought 63.7 K USD
Erlich Craig
Director
+ 1000
63.68 USD
5 years ago
Jun 26, 2019
Bought 642 K USD
RAKOLTA JOHN JR
Director
+ 10000
64.2 USD
5 years ago
May 22, 2019
Bought 50.6 K USD
Erlich Craig
Director
+ 750
67.47 USD
5 years ago
May 03, 2019
Bought 450 K USD
RAKOLTA JOHN JR
Director
+ 6801
66.19 USD
5 years ago
Mar 28, 2019
Sell 48.7 K USD
KALIL FARRIS G.
Director
- 701
69.49 USD
5 years ago
Dec 28, 2018
Bought 9.62 K USD
RAKOLTA JOHN JR
Director
+ 162
59.39 USD
6 years ago
Nov 07, 2018
Sell 203 K USD
Hermiz Laith
COO & EVP
- 3500
58 USD
6 years ago
Sep 06, 2018
Bought 110 K USD
Erlich Craig
Director
+ 2000
54.8 USD
6 years ago
Sep 06, 2018
Bought 329 K USD
AGREE RICHARD
Executive Chairman of Board
+ 6000
54.77 USD
6 years ago
Sep 06, 2018
Bought 40 K USD
Lehmkuhl Greg
Director
+ 730
54.75 USD
6 years ago
Sep 05, 2018
Bought 179 K USD
RAKOLTA JOHN JR
Director
+ 3274
54.69 USD
6 years ago
Sep 05, 2018
Bought 548 K USD
RAKOLTA JOHN JR
Director
+ 10000
54.84 USD
6 years ago
Jul 24, 2018
Bought 11.6 K USD
RAKOLTA JOHN JR
Director
+ 220
52.65 USD
6 years ago
Mar 02, 2018
Bought 235 K USD
RAKOLTA JOHN JR
Director
+ 5000
47 USD
6 years ago
Mar 01, 2018
Bought 235 K USD
RAKOLTA JOHN JR
Director
+ 5000
47.02 USD
6 years ago
Mar 01, 2018
Bought 472 K USD
RAKOLTA JOHN JR
Director
+ 10000
47.17 USD
6 years ago
Feb 28, 2018
Bought 118 K USD
RAKOLTA JOHN JR
Director
+ 2500
47.27 USD
6 years ago
Dec 11, 2017
Bought 50.1 K USD
Thelen Clayton R.
CFO & Secretary
+ 1010
49.56 USD
6 years ago
Nov 30, 2017
Bought 164 K USD
RAKOLTA JOHN JR
Director
+ 3300
49.67 USD
7 years ago
May 17, 2017
Bought 4.51 K USD
Frankel Merrie S.
Director
+ 100
45.12 USD
7 years ago
May 16, 2017
Bought 112 K USD
Rubenfaer William S.
Director
+ 2500
44.92 USD
7 years ago
May 04, 2017
Bought 1.12 M USD
AGREE RICHARD
Executive Chairman of Board
+ 25000
44.73 USD
7 years ago
May 04, 2017
Bought 448 K USD
RAKOLTA JOHN JR
Director
+ 10000
44.82 USD
8 years ago
Nov 14, 2016
Bought 82.2 K USD
Silverman Gene
Director
+ 2000
41.1 USD
8 years ago
Oct 26, 2016
Bought 570 K USD
RAKOLTA JOHN JR
Director
+ 12000
47.5 USD
9 years ago
Aug 24, 2015
Bought 243 K USD
Agree Joey
President and CEO
+ 8400
28.96 USD
9 years ago
Aug 24, 2015
Bought 28.9 K USD
Rubenfaer William S.
Director
+ 1000
28.87 USD
9 years ago
Aug 24, 2015
Bought 86.6 K USD
Rubenfaer William S.
Director
+ 3000
28.86 USD
9 years ago
Aug 24, 2015
Bought 142 K USD
AGREE RICHARD
Executive Chairman
+ 5000
28.48 USD
9 years ago
Aug 24, 2015
Bought 145 K USD
AGREE RICHARD
Executive Chairman
+ 5000
29.01 USD
9 years ago
Aug 24, 2015
Bought 144 K USD
AGREE RICHARD
Executive Chairman
+ 5000
28.84 USD
9 years ago
Jun 26, 2015
Bought 290 K USD
Agree Joey
President and CEO
+ 9809
29.61 USD
9 years ago
Jun 08, 2015
Bought 89.9 K USD
AGREE RICHARD
Executive Chairman
+ 3000
29.96 USD
9 years ago
Jun 08, 2015
Bought 210 K USD
AGREE RICHARD
Executive Chairman
+ 7000
29.98 USD
9 years ago
Jun 03, 2015
Bought 60.3 K USD
Rubenfaer William S.
Director
+ 2000
30.15 USD
9 years ago
Mar 19, 2015
Sell 100 K USD
Hermiz Laith
EVP
- 3000
33.5 USD
9 years ago
Dec 04, 2014
Bought 742 K USD
AGREE RICHARD
Chairman
+ 25000
29.67 USD
9 years ago
Dec 04, 2014
Bought 89 K USD
Rubenfaer William S.
Director
+ 3000
29.67 USD
10 years ago
May 08, 2014
Bought 34 K USD
Rubenfaer William S.
Director
+ 1150
29.59 USD
10 years ago
Mar 27, 2014
Sell 99.3 K USD
Hermiz Laith
EVP
- 3281
30.25 USD
10 years ago
Mar 27, 2014
Sell 726 USD
Hermiz Laith
EVP
- 24
30.26 USD
10 years ago
Dec 20, 2013
Bought 28.3 K USD
Rubenfaer William S.
Director
+ 1000
28.312 USD
10 years ago
Dec 20, 2013
Bought 28 K USD
Rubenfaer William S.
Director
+ 1000
28 USD
10 years ago
Nov 21, 2013
Bought 596 K USD
RAKOLTA JOHN JR
Director
+ 20000
29.8 USD
11 years ago
Mar 27, 2013
Bought 168 K USD
RAKOLTA JOHN JR
Director
+ 6000
28.07 USD
11 years ago
Mar 26, 2013
Bought 193 K USD
RAKOLTA JOHN JR
Director
+ 6977
27.72 USD
11 years ago
Mar 25, 2013
Bought 47.6 K USD
RAKOLTA JOHN JR
Director
+ 1700
28 USD
11 years ago
Mar 25, 2013
Bought 140 K USD
RAKOLTA JOHN JR
Director
+ 5000
28 USD
11 years ago
Mar 22, 2013
Bought 164 K USD
RAKOLTA JOHN JR
Director
+ 5894
27.8 USD
11 years ago
Jan 15, 2013
Bought 1.36 M USD
RAKOLTA JOHN JR
Director
+ 50000
27.25 USD
12 years ago
May 29, 2012
Bought 76.7 K USD
AGREE RICHARD
Chief Executive Officer
+ 3700
20.74 USD
12 years ago
May 25, 2012
Bought 131 K USD
AGREE RICHARD
Chief Executive Officer
+ 6300
20.8 USD
13 years ago
Sep 20, 2011
Bought 4.88 K USD
AGREE RICHARD
Chief Executive Officer
+ 230
21.22 USD
13 years ago
Sep 20, 2011
Bought 31.6 K USD
AGREE RICHARD
Chief Executive Officer
+ 1483
21.28 USD
13 years ago
Sep 20, 2011
Bought 42.6 K USD
AGREE RICHARD
Chief Executive Officer
+ 2000
21.3 USD
13 years ago
Sep 19, 2011
Bought 63.9 K USD
AGREE RICHARD
Chief Executive Officer
+ 3000
21.3 USD
13 years ago
Sep 16, 2011
Bought 42.6 K USD
AGREE RICHARD
Chief Executive Officer
+ 2000
21.28 USD
13 years ago
Sep 06, 2011
Bought 18.4 K USD
RAKOLTA JOHN JR
Director
+ 900
20.4 USD
13 years ago
Sep 02, 2011
Bought 210 K USD
RAKOLTA JOHN JR
Director
+ 10000
20.9765 USD
13 years ago
Aug 26, 2011
Bought 78.7 K USD
RAKOLTA JOHN JR
Director
+ 3759
20.9233 USD
13 years ago
Aug 25, 2011
Bought 131 K USD
RAKOLTA JOHN JR
Director
+ 6241
21 USD
13 years ago
Aug 19, 2011
Bought 85.9 K USD
RAKOLTA JOHN JR
Director
+ 4100
20.9426 USD
13 years ago
Aug 18, 2011
Bought 105 K USD
RAKOLTA JOHN JR
Director
+ 5000
20.949 USD
13 years ago
Aug 17, 2011
Bought 96.3 K USD
RAKOLTA JOHN JR
Director
+ 4452
21.6325 USD
13 years ago
Aug 16, 2011
Bought 120 K USD
RAKOLTA JOHN JR
Director
+ 5548
21.6422 USD
13 years ago
Aug 17, 2011
Bought 96.3 K USD
RAKOLTA JOHN JR
Director
+ 4452
21.6325 USD
13 years ago
Aug 16, 2011
Bought 120 K USD
RAKOLTA JOHN JR
Director
+ 5548
21.6422 USD
13 years ago
Aug 18, 2011
Bought 105 K USD
RAKOLTA JOHN JR
Director
+ 5000
20.949 USD
13 years ago
Aug 10, 2011
Bought 8.2 K USD
Rubenfaer William S.
Director
+ 400
20.51 USD
15 years ago
May 19, 2009
Sell 37.6 K USD
PRUETER DAVID J
Senior Vice President
- 2150
17.5 USD
17 years ago
Jul 26, 2007
Bought 87.8 K USD
Silverman Gene
Director
+ 3041
28.88 USD
17 years ago
Jul 31, 2007
Bought 86 K USD
Agree Joey
Executive Vice President
+ 3000
28.66 USD
17 years ago
Jul 31, 2007
Bought 142 K USD
AGREE RICHARD
President
+ 5000
28.38 USD
18 years ago
Aug 21, 2006
Sell 91.3 K USD
HOWE KENNETH R
Vice President, Finance
- 2800
32.6 USD
7. News
One Stock I've Been Buying This Month And One I'm Looking To Buy PepsiCo and Realty Income have experienced price drops due to high inflation, but both companies remain fundamentally sound with strong long-term growth potential. Food inflation, in particular, has continued to weigh on consumer discretionary stocks like PepsiCo and Coca-Cola. PepsiCo's current valuation offers a forward P/E of 20.24x, below its 5-year average, making it an attractive buy near $160 for potential upside. seekingalpha.com - 2 days ago
Agree Realty price target raised to $80 from $75 at Mizuho Mizuho raised the firm's price target on Agree Realty to $80 from $75 and keeps a Neutral rating on the shares as part of a broader research note. The firm is turning less constructive on Triple Net REITs as expectations of higher inflation and a "higher for longer" rate environment should weigh on the sector's investment spreads and growth potential, marking the end of the "pivot party", the analyst tells investors in a research note. Mizuho adds however Agree Realty stands apart as it has pre-funded its acquisition pipeline, with the management team having issued forward equity to lock in today's stock price. https://thefly.com - 3 days ago
Why Buy Treasuries When You Can Buy Agree Realty Warren Buffett's recent moves into Treasury bonds aren't necessarily suitable for everyday investors, and there are attractive stock opportunities like Agree Realty. ADC offers a 4% dividend yield, a strong balance sheet, and a history of consistent shareholder returns, making it a solid long-term investment. ADC's strategic portfolio management and development initiatives have positioned it well for future growth, with a focus on high-quality, recession-resistant tenants. seekingalpha.com - 3 days ago
Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company BOCA RATON, Fla., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), today announced that it has entered into a binding term sheet for a reverse merger transaction (the “Proposed Merger”) with Journey Therapeutics, Inc. (“Journey”), a privately-held, clinical-stage biopharmaceutical company with a next-generation proprietary modular antibody-drug conjugate (ADC)-like, nano-immunoconjugates (NIC) platform. Upon completion of the Proposed Merger, the shareholders of Journey will acquire 99% of the equity of Entero. The combined company is expected to operate under the name Journey Therapeutics, Inc., and will apply for continued trading on The Nasdaq Capital Market. The completion of the Proposed Merger is subject to several conditions, including the negotiation of definitive agreements, the receipt by Entero of at least $5 million of equity financing, the effectiveness of a registration statement to be filed with the Securities and Exchange Commission and the approval of the stockholders of Entero. globenewswire.com - 4 days ago
Agree Realty Declares Monthly Common and Preferred Dividends ROYAL OAK, Mich. , Nov. 12, 2024  /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that its Board of Directors has authorized, and the Company has declared, a monthly cash dividend of $0.253 per common share. prnewswire.com - 4 days ago
REITs RetREIT? 2 Yielding Over 5% Long-Term Investors Should Consider REITs have recently seen their share prices dip, likely due to the upcoming presidential election as well as rising geopolitical tensions. NNN REIT and VICI Properties are two fundamentally sound REITs that offer long-term investors solid upside potential. Both recently reported strong Q3 earnings with solid FFO, AFFO, and revenue growth on an annualized basis. seekingalpha.com - 5 days ago
2 'Strong Buy' REITs At Steep Discounts REITs have risen considerably already. But not all REITs participated in this rally. I present 2 REITs that remain heavily discounted. seekingalpha.com - 5 days ago
Forget The Election: 3 REITs To Buy Today Macroeconomics trumps politics. REITs are cheap and set to benefit from rate cuts. Here are 3 REITs that win no matter what. seekingalpha.com - 6 days ago
Buy The Dip: Big Dividend Growth Stocks Getting Way Too Cheap High-yield dividend growth stocks have been on a strong run over the past four months. However, there are several that have not participated in the rally and have even dipped sharply in some cases. We share three examples of high-yielding dividend growers that have strong outlooks but are deeply discounted due to short-term issues. seekingalpha.com - 6 days ago
IDEAYA Announces Development Candidate Nomination of IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise with Biocytogen Nominated IDE034 (BCG034) as a development candidate, a potential first-in-class B7H3/PTK7 topo-I-payload bispecific antibody drug conjugate (BsADC) Option exercised for an exclusive worldwide license for IDE034 from Biocytogen Targeting an IND-filing for IDE034 in 2025 to enable first-in-human clinical evaluation of B7H3/PTK7 topo-I-payload BsADC program IDE034 has the potential to be developed as a monotherapy and in combination with IDEAYA's PARG inhibitor IDE161 B7H3/PTK7 co-expression in lung, colorectal, and head and neck cancer, has been reported at approximately 30%, 46% and 27%, respectively SOUTH SAN FRANCISCO, Calif. and BEIJING , Nov. 11, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the selection of IDE034, a potential first-in-class B7H3/PTK7 topo-I-payload BsADC, as a development candidate and the exercise of its option for an exclusive worldwide license from Biocytogen Pharmaceuticals (Beijing) Co., Ltd. prnewswire.com - 6 days ago
Biocytogen Announces IDEAYA's Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise BEIJING & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #ADC--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, has exercised the option for an exclusive worldwide license for Biocytogen's B7H3/PTK7 BsADC program, IDE034, and has n. businesswire.com - 6 days ago
Biocytogen Announces IDEAYA's Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise BEIJING & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #Antibody--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, has exercised the option for an exclusive worldwide license for Biocytogen's B7H3/PTK7 BsADC program, IDE034, and has n. businesswire.com - 6 days ago
8. Profile Summary

Agree Realty Corporation ADC

image
COUNTRY US
INDUSTRY REIT - Retail
MARKET CAP $ 7.86 B
Dividend Yield 1.02%
Description Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol "ADC".
Contact 70 East Long Lake Road, Bloomfield Hills, MI, 48304 https://www.agreerealty.com
IPO Date April 15, 1994
Employees 72
Officers Mr. Reuben Goldman Treatman CPA Senior Director of Corporate Finance Ms. Jessica Katz Director of People & Culture Mr. Marc Brandt Vice President of Asset Management Mr. Josh Bratton Director of Development Mr. Craig Erlich Chief Growth Officer Ms. Nicole Witteveen Chief Operating Officer Mr. Richard A. Agree Executive Chairman of the Board Mr. Peter Coughenour Chief Financial Officer, Secretary & Investor Relations Professional Mr. Larry Kaufman Chief Information Officer & Vice President of Continuous Improvement Mr. Stephen Breslin Chief Accounting Officer